Pre-book 2026

AI is already making calls inside GxP systems.

The validation playbooks haven't caught up.

For three years I kept reaching for a reference that did not exist: one practitioner guide that takes AI and ML validation in regulated pharma from the strategy a board needs in 90 seconds down to something a quality lead can act on Monday morning. So I wrote it.

19 chapters46 templates280 pages22 frameworks mapped
Validating AI in GxP Environments: A Practitioner's Handbook by Sachin Bhandari

Validating AI in GxP Environments

The Practitioner Handbook · Sachin Bhandari

Pre-book now. You'll get a discount code the day it launches.

No spam. Just the launch notification and your discount.

Validating AI in GxP Environments

The Practitioner Handbook · Sachin Bhandari · PDF edition

Detecting your region…
Have a discount code?

Digital PDF · Personalised watermark · Download link emailed instantly

Your download link goes to the email you enter at checkout. Please type it carefully: a wrong address never receives the book and cannot be recovered later.

€500
Company-named edition · Unlimited internal use
Includes a named title page and per-page licence footer identifying your organisation.
Single-site biotech, small CDMO, or academic? We have reduced pricing for smaller organisations. Tell us about your organisation and we'll send the right code.
Named work email only

Already bought? Resend my download link

What the book covers

The gap between "we use AI" and "we can defend it in an inspection" comes down to three things: how the risk was classified, whether the governance holds under scrutiny, and how well the evidence was built. This book works through each in sequence, from the first board conversation to the post-deployment monitoring plan.

Plus 15 appendices: 46 templates, SOPs, QRGs, an inspection question bank, a vendor-assessment framework, an Annex 22 evidence pack, and worked examples throughout.